The mammalian target of rapamycin (mTOR), an intracellular protein kinase within the phosphoinositide-3 kinase family, is a pivotal component in the cell signalling pathway that contributes to the development of neuroendocrine tumors. The gene discussed is MTOR; the disease is neuroendocrine neoplasm.